Trials / Completed
CompletedNCT01542502
Pilot Feasibility Study of the Safety and Efficacy of Anakinra in Heart Failure With Preserved Ejection Fraction
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Virginia Commonwealth University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This will be a randomized, double-blind, crossover pilot study to measure the safety and feasibility of Interleukin-1 (IL-1) blockade with Anakinra in patients with stable heart failure with preserved ejection fraction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Anakinra | Anakinra 100 mg daily subcutaneous injection |
| DRUG | Placebo | Placebo daily subcutaneous injection |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2012-03-02
- Last updated
- 2017-02-06
- Results posted
- 2016-04-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01542502. Inclusion in this directory is not an endorsement.